RT Conference Proceedings
T1 HER2/neu 655 A > G polymorphism is associated with higher cardiotoxicity but not with less efficacy of trastuzumab, in HER2-positive breast cancer patients
A1 Blancas, I.
A1 Rodriguez-Serrano, F.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/26021
UL https://hdl.handle.net/10668/26021
LA en
DS RISalud
RD Apr 12, 2025